Dr. Howard Smith Reports

Vidcast:  https://youtu.be/dFOqc9qu60g

Breakthrough infections were 66% more likely in those vaccinated with Pfizer in comparison with those receiving Moderna.  Biomedical informatics researchers at New York City’s Columbia University conducted a retrospective analysis of 198 patients suffering breakthrough CoVid infections following vaccination with an mRNA vaccine.  Of the group, 21% received the Moderna and 79% the Pfizer.  A control group consisted of 14,164 vaccinated individuals who remained free of subsequent CoVid.

The overall breakthrough infection rate was 16%, for Pfizer 19%, and for Moderna 10%.  Besides vaccination with Pfizer, other associated factors that raised the risk of a breakthrough CoVid infection were male gender 47% higher and having a compromised immune system 48% higher.   Those with chronic lung disorders had a 3-4 times higher risk.

https://www.medrxiv.org/content/10.1101/2021.10.05.21264583v1.full.pdf

#CoVid #mRNAvaccines #Moderna #Pfizer #breakthrough

Vidcast:  https://youtu.be/dFOqc9qu60g

Breakthrough infections were 66% more likely in those vaccinated with Pfizer in comparison with those receiving Moderna.  Biomedical informatics researchers at New York City’s Columbia University conducted a retrospective analysis of 198 patients suffering breakthrough CoVid infections following vaccination with an mRNA vaccine.  Of the group, 21% received the Moderna and 79% the Pfizer.  A control group consisted of 14,164 vaccinated individuals who remained free of subsequent CoVid.

The overall breakthrough infection rate was 16%, for Pfizer 19%, and for Moderna 10%.  Besides vaccination with Pfizer, other associated factors that raised the risk of a breakthrough CoVid infection were male gender 47% higher and having a compromised immune system 48% higher.   Those with chronic lung disorders had a 3-4 times higher risk.

https://www.medrxiv.org/content/10.1101/2021.10.05.21264583v1.full.pdf

#CoVid #mRNAvaccines #Moderna #Pfizer #breakthrough

Vidcast:  https://youtu.be/8l8KbQFbEIM

When Delta CoVid infects children and teens, the duration of symptomatic illness and the need for hospitalization is about the same as for the initial British variant.  London researchers studied 694 kids who tested positive for CoVid during the Delta predominant May to July 2021 and compared their data to 706 kids who tested positive during the Alpha predominant December to May.

The median illness duration was 5 days with a range of 2 to 9 days for either Delta or Alpha. The median duration by age for both variants for the younger 5-11 year old children was 4 days (3-8d) and 2 days longer at 6 days (4-10d) for older 12-17 year old children.  The 7 most prevalent symptoms were the same for both variants:  headache, fatigue, fever, smell issues, sneezing, runny nose, and sore throat.  Symptoms tended to be more prominent with Delta than with Alpha.

Hospitalization for Delta CoVid was necessary for 3.5% of younger kids and 1.7% of the older ones.  For Alpha, it was 2.2% of younger and 1.9% of older.

https://www.medrxiv.org/content/10.1101/2021.10.06.21264467v1.full.pdf

#CoVid #delta #children #duration #hospitalization

Vidcast:  https://youtu.be/8l8KbQFbEIM

When Delta CoVid infects children and teens, the duration of symptomatic illness and the need for hospitalization is about the same as for the initial British variant.  London researchers studied 694 kids who tested positive for CoVid during the Delta predominant May to July 2021 and compared their data to 706 kids who tested positive during the Alpha predominant December to May.

The median illness duration was 5 days with a range of 2 to 9 days for either Delta or Alpha. The median duration by age for both variants for the younger 5-11 year old children was 4 days (3-8d) and 2 days longer at 6 days (4-10d) for older 12-17 year old children.  The 7 most prevalent symptoms were the same for both variants:  headache, fatigue, fever, smell issues, sneezing, runny nose, and sore throat.  Symptoms tended to be more prominent with Delta than with Alpha.

Hospitalization for Delta CoVid was necessary for 3.5% of younger kids and 1.7% of the older ones.  For Alpha, it was 2.2% of younger and 1.9% of older.

https://www.medrxiv.org/content/10.1101/2021.10.06.21264467v1.full.pdf

#CoVid #delta #children #duration #hospitalization

Vidcast:  https://youtu.be/C4eRhT9I5LI

When a breastfeeding woman receives an mRNA CoVid vaccine, NONE of the mRNA finds its way into her breastmilk.  This from a UC-San Francisco study of 13 milk samples collected from 7 lactating women who had been vaccinated with either Pfizer or Moderrna vaccines between 4 to 48 hours earlier.

The results are uncomplicated.  The mRNA injected intramuscularly in the deltoid muscle of the shoulder does not find its way into a woman’s mammary glands or into her breastmilk at any time within 2 days after vaccination.  We know that vaccine mRNA is quickly degraded in the body during this timeframe. 

Now contrast that result with other data that shows breastmilk from previously vaccinated women contains protective anti-CoVid antibodies.  Such antibodies may also pass from a vaccinated pregnant woman to her developing fetus via the placenta.

Bottom line:  women who are contemplating pregnancy or are already pregnant should be vaccinated against CoVid.

https://jamanetwork.com/journals/jamapediatrics/fullarticle/2781679https://www.nebraskamed.com/COVID/where-mrna-vaccines-and-spike-proteins-go

#covid #mRNA #vaccine #breastmilk #breastfeeding

Vidcast:  https://youtu.be/C4eRhT9I5LI

When a breastfeeding woman receives an mRNA CoVid vaccine, NONE of the mRNA finds its way into her breastmilk.  This from a UC-San Francisco study of 13 milk samples collected from 7 lactating women who had been vaccinated with either Pfizer or Moderrna vaccines between 4 to 48 hours earlier.

The results are uncomplicated.  The mRNA injected intramuscularly in the deltoid muscle of the shoulder does not find its way into a woman’s mammary glands or into her breastmilk at any time within 2 days after vaccination.  We know that vaccine mRNA is quickly degraded in the body during this timeframe. 

Now contrast that result with other data that shows breastmilk from previously vaccinated women contains protective anti-CoVid antibodies.  Such antibodies may also pass from a vaccinated pregnant woman to her developing fetus via the placenta.

Bottom line:  women who are contemplating pregnancy or are already pregnant should be vaccinated against CoVid.

https://jamanetwork.com/journals/jamapediatrics/fullarticle/2781679https://www.nebraskamed.com/COVID/where-mrna-vaccines-and-spike-proteins-go

#covid #mRNA #vaccine #breastmilk #breastfeeding

Vidcast:  https://youtu.be/GOBbF_BIXIg

Not going to beat around the bush here—American are wayyyyyyy too BIG.  According to the CDC’s latest report, 1 in every 5 Americans, that’s 20% of us, is obese.  And it’s even worse in some states and for certain groups of us.

Obesity is most prevalent in the South and Midwest with a 34% rate.  Not much better overall in the West and Northeast which weigh in at 29% and 28%.

Groupwise, those most likely to be obese are 45-51 years of age at 38%.  Those least likely are 18 to 24 years at 19.5%.  Among America’s racial and ethnic groups, those least likely to be obese are Asians at 17.%.  Far heavier on the health scale are White adults art 42.2%, Hispanic adults at 44.8%, and Black adults at 50%.

Obesity has a huge negative impact on health as a trigger for cardiovascular disease, diabetes, and, yes, CoVid.  Some 30% of adult CoVid hospitalizations as of last year were directly linked to obesity.

https://www.cdc.gov/obesity/index.html

https://www.mdlinx.com/article/america-s-big-health-problem-just-got-bigger/36B451N8xLyVPdHuzF5YHv?tag=Morning&utm_campaign=malert_101021_M3Learning&utm_source=iPost&utm_medium=email&ipost_environment=m3usainc&iqs=9z2zur53l6qc13hl5igfgfoujovvva6cre40o2qojq0

#obesity #CoVid #ethnicity #age #states 

Vidcast:  https://youtu.be/GOBbF_BIXIg

Not going to beat around the bush here—American are wayyyyyyy too BIG.  According to the CDC’s latest report, 1 in every 5 Americans, that’s 20% of us, is obese.  And it’s even worse in some states and for certain groups of us.

Obesity is most prevalent in the South and Midwest with a 34% rate.  Not much better overall in the West and Northeast which weigh in at 29% and 28%.

Groupwise, those most likely to be obese are 45-51 years of age at 38%.  Those least likely are 18 to 24 years at 19.5%.  Among America’s racial and ethnic groups, those least likely to be obese are Asians at 17.%.  Far heavier on the health scale are White adults art 42.2%, Hispanic adults at 44.8%, and Black adults at 50%.

Obesity has a huge negative impact on health as a trigger for cardiovascular disease, diabetes, and, yes, CoVid.  Some 30% of adult CoVid hospitalizations as of last year were directly linked to obesity.

https://www.cdc.gov/obesity/index.html

https://www.mdlinx.com/article/america-s-big-health-problem-just-got-bigger/36B451N8xLyVPdHuzF5YHv?tag=Morning&utm_campaign=malert_101021_M3Learning&utm_source=iPost&utm_medium=email&ipost_environment=m3usainc&iqs=9z2zur53l6qc13hl5igfgfoujovvva6cre40o2qojq0

#obesity #CoVid #ethnicity #age #states 

Vidcast:  https://youtu.be/h6zKanQqta8

Overall, a booster of the Pfizer mRNA CoVid vaccine produces a 10-fold lower infection rate when boosted and non-boosted populations are compared.  Israeli researchers studied data from 4,621,836 persons over the months of August and September of this year.

Looking at the incidence of severe CoVid in various age groups who were either boosted or not, those over age 60 who were boosted were nearly 19 fold (18.7) less likely to develop a severe infection.  Those 40-60 years of age and boosted were 22% less likely to develop that severe CoVid.  For those 60 and above, boosting reduced the death rate 14.7 fold.

Since Israel was the first country to implement a large-scale CoVid booster program, their data may help guide all Americans to the conclusion that CoVid boosters at the proper time may be lifesaving. 

https://www.medrxiv.org/content/10.1101/2021.10.07.21264626v1.full.pdf

#CoVid #booster #mortality

Vidcast:  https://youtu.be/h6zKanQqta8

Overall, a booster of the Pfizer mRNA CoVid vaccine produces a 10-fold lower infection rate when boosted and non-boosted populations are compared.  Israeli researchers studied data from 4,621,836 persons over the months of August and September of this year.

Looking at the incidence of severe CoVid in various age groups who were either boosted or not, those over age 60 who were boosted were nearly 19 fold (18.7) less likely to develop a severe infection.  Those 40-60 years of age and boosted were 22% less likely to develop that severe CoVid.  For those 60 and above, boosting reduced the death rate 14.7 fold.

Since Israel was the first country to implement a large-scale CoVid booster program, their data may help guide all Americans to the conclusion that CoVid boosters at the proper time may be lifesaving. 

https://www.medrxiv.org/content/10.1101/2021.10.07.21264626v1.full.pdf

#CoVid #booster #mortality